Page last updated: 2024-08-23

bisantrene and Diathesis

bisantrene has been researched along with Diathesis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Avigdor, A; Benjamini, O; Canaani, J; Danylesko, I; Dor, C; Lozinsky, K; Nagar, M; Nagler, A; Shemtov, N; Shimoni, A; Yerushalmi, R; Zlotnick, M	1

Trials

1 trial(s) available for bisantrene and Diathesis

Article	Year
A phase II study of bisantrene in patients with relapsed/refractory acute myeloid leukemia. European journal of haematology, 2021, Volume: 106, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Anthracenes; Antibiotics, Antineoplastic; Biopsy; Bone Marrow; Disease Susceptibility; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Recurrence; Retreatment; Treatment Outcome; Young Adult	2021

Article

Year

A phase II study of bisantrene in patients with relapsed/refractory acute myeloid leukemia.

European journal of haematology, 2021, Volume: 106, Issue:2

Topics: Adult; Aged; Aged, 80 and over; Anthracenes; Antibiotics, Antineoplastic; Biopsy; Bone Marrow; Disease Susceptibility; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Recurrence; Retreatment; Treatment Outcome; Young Adult

2021